Stock comparison
Novartis AG is 245.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($309.21 B vs $1.26 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 245.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($309.21 B vs $1.26 B).
Market value leader
NVS
Novartis AG is 245.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($309.21 B vs $1.26 B).
| Metric | NKTR | NVS |
|---|---|---|
| Market cap | $1.26 B | $309.21 B |
| US-listed rank | #2413 | #38 |
| Revenue (latest FY) | $55.23M | - |
| Net income (latest FY) | -$164.00M | - |
| Net margin | -296.9% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 1,946 | 953 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 245.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($309.21 B vs $1.26 B).
Full pages: NEKTAR THERAPEUTICS and Novartis AG, or browse the full rankings.